Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Jan, Dutz"'
Publikováno v:
RMD Open, Vol 10, Iss 1 (2024)
Objectives To evaluate the effectiveness and safety of upadacitinib in treatment-refractory inflammatory myositis.Methods Patients with refractory inflammatory myositis treated with upadacitinib from a single urban centre in Vancouver, British Columb
Externí odkaz:
https://doaj.org/article/690d5f7e113f4a8f86953429e8a042f6
Autor:
Hermenio Lima, Melinda Gooderham, Jan Dutz, Charles Lynde, Hugo Chapdelaine, Anne Ellis, Martin Gilbert, Vincent Ho, Kim Papp, Yves Poulin, Gordon Sussman
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 13, Iss 1, Pp 1-7 (2017)
Abstract Background Treat-to-target therapy approaches are established for chronic diseases such as diabetes, hypertension, and more recently rheumatoid arthritis, resulting in improved patient outcomes. These approaches do not use patient reported o
Externí odkaz:
https://doaj.org/article/26a81df6249048a9880c07159c88a827
Autor:
Misha Zarbafian, Jan Dutz, MD, FRCPC
Publikováno v:
JAAD Case Reports, Vol 3, Iss 1, Pp 45-48 (2017)
Externí odkaz:
https://doaj.org/article/79cf61e7eae744dc8f30d55e3ee8d7c4
Autor:
François, Lagacé, Elena, Netchiporouk, Irina, Turchin, Wayne, Gulliver, Jan, Dutz, Mark G, Kirchhof, Popradi, Popradi, Robert, Gniadecki, Charles, Lynde, Ivan V, Litvinov
Publikováno v:
Skin therapy letter. 27(5)
Extracorporeal photopheresis (ECP) is an immunomodulatory therapy that has been used for over 35 years to treat numerous conditions. ECP was initially approved by the US FDA in 1988 for the treatment of Sézary syndrome, a leukemic form of cutaneous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1ab06cdaeebcc86f6d3405e4f4b2ba55
https://pubmed.ncbi.nlm.nih.gov/36469458
https://pubmed.ncbi.nlm.nih.gov/36469458
Publikováno v:
Clinics in dermatology.
Chilblain-like lesions (CLL) coinciding with SARS-CoV-2 infection have been described. Previous systematic reviews suggest CLL are associated with younger age, an equal sex ratio, negative testing for SARS-CoV-2, and mild to no extracutaneous symptom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7ac96580f27bb4bc026f28d04cefffa
https://pubmed.ncbi.nlm.nih.gov/36228990
https://pubmed.ncbi.nlm.nih.gov/36228990
Publikováno v:
Journal of Cutaneous Medicine and Surgery. :120347542311580
Chilblain-like lesions (CLL) coinciding with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection have been described in the literature. Available reviews of the literature suggest that CLL are associated with younger age, an equal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36b5711fa3d0f1ce90f205e4c39543bc
https://doi.org/10.1177/12034754231158074
https://doi.org/10.1177/12034754231158074
Autor:
Scott A. Elman, AB, Filippa Nyberg, MD, Fukumi Furukawa, MD, Mark Goodfield, MD, Minoru Hasegawa, MD, Branka Marinovic, MD, Jacek Szepietowski, MD, Jan Dutz, MD, FRCPC, Victoria P. Werth, MD, Joseph F. Merola, MD, MMSc
Publikováno v:
International Journal of Women's Dermatology, Vol 2, Iss 2, Pp 44-45 (2016)
Currently, no standardized classification criteria exist for cutaneous lupus erythematosus. With increased interest in studying cutaneous lupus erythematosus, specifically discoid lupus erythematosus, it is our aim to apply previously adopted methods
Externí odkaz:
https://doaj.org/article/ce50acb89a9a4eb6ab1b5bdd9fca5780